Mode
Text Size
Log in / Sign up
N/A N=30 Randomized Triple-blind Supportive Care

Goal Directed Therapy Versus Standard Care in Lung Resection Surgery (GDT-thorax Study).

Goal Directed Therapy · Fluid Therapy

Enrolled (actual)
30
Serious AEs
23.3%
Results posted
Oct 2021
Primary outcome: Primary: Percentage of the Intraoperative Time in Which the Cardiac Index is Equal or Superior to 2.2 l/Min/m2 (%) — 97; 91 percentage of time — p=0.114

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Standard care (Procedure); Goal directed therapy (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Primary completion
Mar 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of the Intraoperative Time in Which the Cardiac Index is Equal or Superior to 2.2 l/Min/m2 (%)
97; 91 0.114
SECONDARY
Tissue Perfusion Marker: Lactate
0.70; 0.80 0.692
SECONDARY
Tissue Perfusion Marker: SvcO2
66.03; 70.16 0.082
SECONDARY
Oxygenation Marker: PaO2/FiO2 Ratio
331.43; 339.05 0.443
SECONDARY
Fluid Balance
647.17; 748.83 0.668
SECONDARY
Observation of Acute Kidney Injury (AKI)
3; 5 0.516
SECONDARY
Observation of Acute Respiratory Distress Syndrome (ARDS)
0; 0
SECONDARY
Duration of Hospital Stay
4; 5 0.229
SECONDARY
Mortality
1; 0 1

Summary

The primary aim of this study is to quantify and compare the hemodynamic control of cardiac index in patients who receive either goal-directed therapy or standard hemodynamic management in lung resection surgery

Eligibility Criteria

Inclusion Criteria

  • Adults patients ( 18 years old)
  • Written informed consent
  • Elective lung resection surgery (open or thoracoscopic lung lobectomy)

Exclusion Criteria

  • Severe obesity
  • Moderate to severe aortic insufficiency
  • Renal failure requiring hemodialysis
  • Left ventricle ejection fraction less than 35 %
  • Urgent surgery
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03245372). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search